Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 17/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 12/20 | 0.40 |
| ▸ | PDE4A | P27815 | 11/20 | 0.39 |
| ▸ | PDE4C | Q08493 | 11/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5748483 | 0.86 | PDE4B (0.43) | PDE4BPDE4DPDE4APDE4C | |
| SCHEMBL5737268 | 0.84 | PDE4B (0.43) | PDE4BPDE4DPDE4APDE4CLMNA | |
| SCHEMBL4026379 | 0.83 | PDE4D (0.52) | PDE4BPDE4DPDE4APDE4C | |
| SCHEMBL4026393 | 0.74 | PDE4D (0.55) | PDE4BPDE4DPDE4APDE4C | |
| SCHEMBL4030312 | 0.72 | PDE4D (0.52) | PDE4BPDE4DPDE4APDE4C | |
| SCHEMBL4032068 | 0.70 | PDE4D (0.57) | PDE4BPDE4DPDE4APDE4C | |
| SCHEMBL14532422 | 0.70 | POLB (0.47) | PDE4BKDM4EPDE4DPDE4APDE4C | |
| SCHEMBL5016450 | 0.69 | PDE4D (0.57) | PDE4BPDE4DPDE4APDE4C | |
| SCHEMBL5016433 | 0.69 | PDE4D (0.58) | PDE4BPDE4DPDE4APDE4C | |
| SCHEMBL4027963 | 0.68 | PDE4D (0.56) | PDE4BPDE4DPDE4APDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1620429-A1 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Glenmark Pharmaceuticals S.A. (CH) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004089940-A1 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS S.A. (US) | 2004-10-21 | — | — | WO | disclosed |